Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.55% |
| 2 | Financials | 7.82% |
| 3 | Consumer Discretionary | 7.65% |
| 4 | Communication Services | 5.12% |
| 5 | Healthcare | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDTX
3776
DELISTED
Cidara Therapeutics
CDTX
| $275K | ﹤0.01% |
5,643
+5,066
| +878% | +$122K |
|
3777
Invesco DB Commodity Index Tracking Fund
DBC
$1.71B
| $275K | ﹤0.01% |
12,600
-1,311
| -9% | -$28.1K |
|
3778
First Trust Financials AlphaDEX Fund
FXO
$1.15B
| $272K | ﹤0.01% |
4,858
+1,637
| +51% | +$85.7K |
|
|
VNET
3779
VNET Group
VNET
$2.12B
| $271K | ﹤0.01% |
39,308
+6,438
| +20% | +$38.6K |
|
3780
Dimensional Inflation-Protected Securities ETF
DFIP
$1.14B
| $271K | ﹤0.01% |
6,475
-154
| -2% | -$6.4K |
|
3781
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.26B
| $270K | ﹤0.01% |
5,986
+66
| +1% | +$2.89K |
|
3782
BlueLinx
BXC
$705M
| $270K | ﹤0.01% |
3,624
-3,754
| -51% | -$262K |
|
3783
LifeMD
LFMD
$167M
| $269K | ﹤0.01% |
19,767
-5,976
| -23% | -$56.4K |
|
|
SERV
3784
Serve Robotics
SERV
$428M
| $268K | ﹤0.01% |
23,452
+8,206
| +54% | +$72.1K |
|
|
NAGE
3785
Niagen Bioscience
NAGE
$241M
| $268K | ﹤0.01% |
18,610
-16,656
| -47% | -$164K |
|
3786
Vitamin Cottage Natural Grocers
NGVC
$646M
| $268K | ﹤0.01% |
6,818
-545
| -7% | -$25.2K |
|
3787
iShares MSCI ACWI ex US ETF
ACWX
$12B
| $266K | ﹤0.01% |
4,367
+1,746
| +67% | +$101K |
|
3788
Clearfield
CLFD
$390M
| $266K | ﹤0.01% |
6,129
-5,454
| -47% | -$187K |
|
3789
iShares Morningstar Small-Cap Value ETF
ISCV
$710M
| $265K | ﹤0.01% |
4,324
+124
| +3% | +$7.23K |
|
3790
CALL
Novavax
NVAX
$1.34B
| $265K | ﹤0.01% |
42,000
| – | – |
|
3791
iRadimed
IRMD
$1.11B
| $265K | ﹤0.01% |
4,424
-3,194
| -42% | -$175K |
|
3792
Cerence
CRNC
$389M
| $264K | ﹤0.01% |
25,899
-6,814
| -21% | -$60K |
|
3793
Altimmune
ALT
$560M
| $264K | ﹤0.01% |
68,181
-95,337
| -58% | -$516K |
|
3794
Smith & Wesson
SWBI
$643M
| $262K | ﹤0.01% |
30,188
-20,839
| -41% | -$197K |
|
|
LENZ
3795
LENZ Therapeutics
LENZ
$145M
| $262K | ﹤0.01% |
8,930
-781
| -8% | -$21.2K |
|
3796
MetroCity Bankshares
MCBS
$1.05B
| $261K | ﹤0.01% |
9,135
-5,869
| -39% | -$163K |
|
3797
Evolus
EOLS
$530M
| $261K | ﹤0.01% |
28,293
-23,063
| -45% | -$236K |
|
3798
Paysafe
PSFE
$405M
| $260K | ﹤0.01% |
20,637
-3,860
| -16% | -$52.8K |
|
|
CVAC
3799
DELISTED
CureVac
CVAC
| $260K | ﹤0.01% |
47,959
+34,861
| +266% | +$138K |
|
|
GPGI
3800
GPGI Inc
GPGI
$3.75B
| $260K | ﹤0.01% |
18,456
-806
| -4% | -$9.88K |
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup withdrew a net $14.6B in Q2 2025, closing 377 positions and reducing 2,974 holdings. Its most notable exit was James Hardie Industries, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Amrize Ltd worth $114M.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 468 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.